Immunovia AB (publ) (IMMVF) Financials
IMMVF Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| March 31, 2026 | 6.8 million | 2.0 million |
| Dec. 31, 2025 | 9.6 million | 2.5 million |
| Sept. 30, 2025 | 4.0 million | 4.9 million |
| June 30, 2025 | 3.7 million | 1.8 million |
IMMVF Free Cash Flow and Stock based compensation
No data available :(
IMMVF Net Income
No data available :(
IMMVF Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| March 31, 2026 | 5.8 million | - | - |
| Dec. 31, 2025 | 8.4 million | - | 93076 |
| Sept. 30, 2025 | 2.8 million | - | - |
| June 30, 2025 | 3.1 million | - | - |
IMMVF Shares Outstanding
IMMVF Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| March 31, 2026 | - | - | - | - |
| Dec. 31, 2025 | - | 465841 | -465841 | - |
| Sept. 30, 2025 | 590197 | - | - | - |
| June 30, 2025 | - | 76939 | 2.1 million | - |
IMMVF Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| March 31, 2026 | 38936 | 1.9 million |
| Dec. 31, 2025 | 38349 | 1.8 million |
| Sept. 30, 2025 | 10723 | 3822 |
| June 30, 2025 | 9520 | 223831 |
IMMVF
Price: $0.02
52 week price:
Earnings Per Share: -0.04 USD
Exchange: PNK
Sector: Healthcare
Industry: Diagnostics & Research
Market Capitalization: 13.5 million